These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 36435802)
1. Current situation and future direction of Newcastle disease vaccines. Hu Z; He X; Deng J; Hu J; Liu X Vet Res; 2022 Nov; 53(1):99. PubMed ID: 36435802 [TBL] [Abstract][Full Text] [Related]
2. Newcastle disease vaccines-A solved problem or a continuous challenge? Dimitrov KM; Afonso CL; Yu Q; Miller PJ Vet Microbiol; 2017 Jul; 206():126-136. PubMed ID: 28024856 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of Newcastle disease LaSota vaccine-induced hemagglutination inhibition antibodies against challenges with heterologous virulent strains of genotypes VII and IX. Liu M; Shen X; Li J; Yu Y; Fan J; Jia X; Dai Y Vet Immunol Immunopathol; 2023 May; 259():110591. PubMed ID: 37030151 [TBL] [Abstract][Full Text] [Related]
4. Investigation of suspected Newcastle disease (ND) outbreaks in Egypt uncovers a high virus velogenic ND virus burden in small-scale holdings and the presence of multiple pathogens. Moharam I; Razik AAE; Sultan H; Ghezlan M; Meseko C; Franzke K; Harder T; Beer M; Grund C Avian Pathol; 2019 Oct; 48(5):406-415. PubMed ID: 31090444 [TBL] [Abstract][Full Text] [Related]
5. Protective efficacy of the Newcastle disease virus genotype VII-matched vaccine in commercial layers. Sultan HA; Talaat S; Elfeil WK; Selim K; Kutkat MA; Amer SA; Choi KS Poult Sci; 2020 Mar; 99(3):1275-1286. PubMed ID: 32111305 [TBL] [Abstract][Full Text] [Related]
6. Newcastle disease virus outbreaks: vaccine mismatch or inadequate application? Dortmans JC; Peeters BP; Koch G Vet Microbiol; 2012 Nov; 160(1-2):17-22. PubMed ID: 22655976 [TBL] [Abstract][Full Text] [Related]
7. Recombinant Newcastle disease virus (NDV) La Sota expressing the haemagglutinin-neuraminidase protein of genotype VII NDV shows improved protection efficacy against NDV challenge. Bu YW; Yang HM; Jin JH; Zhao J; Xue J; Zhang GZ Avian Pathol; 2019 Apr; 48(2):91-97. PubMed ID: 30465608 [TBL] [Abstract][Full Text] [Related]
11. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine. Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117 [TBL] [Abstract][Full Text] [Related]
12. Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homologous and heterologous DNA vaccination in chickens. Mohamed MH; Abdelaziz AM; Kumar S; Al-Habib MA; Megahed MM Avian Pathol; 2016; 45(2):228-34. PubMed ID: 26813237 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of genotype-matched Newcastle disease virus vaccine formulated in carboxymethyl sago starch acid hydrogel in chickens vaccinated via different routes. Mahamud SNA; Bello MB; Ideris A; Omar AR J Vet Sci; 2022 Jul; 23(4):e25. PubMed ID: 35920119 [TBL] [Abstract][Full Text] [Related]
14. Protection conferred by commercial NDV live attenuated and double recombinant HVT vaccines against virulent California 2018 Newcastle disease virus (NDV) in chickens. Ferreira HL; Reilley AM; Goldenberg D; Ortiz IRA; Gallardo RA; Suarez DL Vaccine; 2020 Jul; 38(34):5507-5515. PubMed ID: 32591288 [TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens. Sedeik ME; Elbestawy AR; El-Shall NA; Abd El-Hack ME; Saadeldin IM; Swelum AA Poult Sci; 2019 May; 98(5):2000-2007. PubMed ID: 30561723 [TBL] [Abstract][Full Text] [Related]
16. Biological characterization of wild-bird-origin avian avulavirus 1 and efficacy of currently applied vaccines against potential infection in commercial poultry. El Naggar RF; Rohaim MA; Bazid AH; Ahmed KA; Hussein HA; Munir M Arch Virol; 2018 Oct; 163(10):2743-2755. PubMed ID: 29922856 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic and Vaccination Approaches for Newcastle Disease Virus in Poultry: The Current and Emerging Perspectives. Bello MB; Yusoff K; Ideris A; Hair-Bejo M; Peeters BPH; Omar AR Biomed Res Int; 2018; 2018():7278459. PubMed ID: 30175140 [TBL] [Abstract][Full Text] [Related]
18. Generation and evaluation of a vaccine candidate of attenuated and heat-resistant genotype VIII Newcastle disease virus. Ruan B; Liu Q; Chen Y; Niu X; Wang X; Zhang C; Guo M; Zhang X; Cao Y; Wu Y Poult Sci; 2020 Jul; 99(7):3437-3444. PubMed ID: 32616237 [TBL] [Abstract][Full Text] [Related]
19. The protection conferred against virulent Newcastle disease virus (vNDV) genotype VII by commercial double recombinant HVT vaccines and NDV live-attenuated vaccine as prime/boost vaccination regimens in commercial broiler chickens carrying maternally-derived antibodies (MDAs) against NDV. Ghanem IAE; Abdullatif TM; Hassanin O Avian Pathol; 2023 Aug; 52(4):251-263. PubMed ID: 37158499 [TBL] [Abstract][Full Text] [Related]
20. A novel genotype VII Newcastle disease virus vaccine candidate generated by mutation in the L and F genes confers improved protection in chickens. Ji Y; Liu T; Du Y; Cui X; Yu Q; Wang Z; Zhang J; Li Y; Zhu Q Vet Microbiol; 2018 Mar; 216():99-106. PubMed ID: 29519533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]